journal article·2021-01-01

Protein adsorption phenomena in hemodialysis membranes: Mechanisms, influences of clinical practices, modeling, and challenges

Heloisa Westphalen, Amira Abdelrasoul, Ahmed Shoker

Publisher page

Abstract

Abstract Kidney failure affects a significant part of the world's population where more than 2 million people currently undergoing some sort of treatment for end-stage kidney disease (ESKD). One of the most common treatments is hemodialysis (HD) which consists of an extracorporeal membrane-based therapy that can retain toxins and remove excess fluid. However, patients can experience short- and long-term life-threatening complications associated with protein adsorption to the HD membrane. Upon contact between blood and membrane, protein adsorption takes place incautiously promoting the build-up of a cake layer and activation of complex reactions called biochemical cascades. The mechanisms of protein adsorption can be complex due to the highly heterogeneous composition of blood and are still not fully understood. Membrane properties such as biocompatibility and surface roughness play a critical role in protein adsorption since it influences the affinity between membrane material and blood components. Also, the HD operating conditions in the clinical practices can significantly influence protein adsorption and play a critical role in the cell rupture pathway which can enhance the adsorption process. Modeling and predicting membrane fouling and protein adsorption in HD have a great potential to guide the definition of adequate operating conditions for HD treatment but still limited. Predictive models can indicate how to manipulate blood and dialysate flow rate, operating pressure, and treatment time to yield better control of protein adsorption, reducing the side effects that are linked to unacceptably high morbidity and mortality rates. This critical review will focus on a comprehensive understanding of the protein adsorption phenomenon, including its mechanisms, its influential factors, and the blood activations and the consequences associated with this phenomenon. Also, and current models and challenges for predicting protein adsorption and membrane fouling are reviewed. Moreover, this review will cover how there is a distinct lack of knowledge when it comes to currently hypothesized mechanistic aspects and their translation into mathematical concepts and models to predict protein adsorption and hemodialysis membrane performance. The models seen so far lack in describing multiprotein adsorption as a function of hemodialysis operating conditions and correlation with patient outcomes.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dialysis and Renal Disease Management · Central Venous Catheters and Hemodialysis · Muscle and Compartmental Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Clinical implications of hemodialysis membrane biocompatibility10.1038/ki.1993.272 ↗
2. Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis
3. Examining hemodialyzer membrane performance using proteomic technologies10.2147/TCRM.S150824 ↗
4. Proteomics investigations into serum proteins adsorbed by high-flux and low-flux dialysis membranes
5. Advances in polysulfone-based membranes for hemodialysis
6. The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates10.1016/j.colsurfb.2012.10.039 ↗
7. The blood compatibility challenge. Part 2: protein adsorption phenomena governing blood reactivity10.1016/j.actbio.2019.06.022 ↗
8. The effect of surface charge on cellular uptake and inflammatory behavior of carbon dots10.1016/j.colcom.2020.100243 ↗
9. Preparation of Zwitterionic Polymer-Functionalized Cotton Fabrics and the Performance of Anti-Biofouling and Long-Term Biofilm Resistance10.1016/j.colcom.2018.02.001 ↗
10. Vascular endothelial cells mediated the indirect effect of mPEG-PCL copolymers on blood coagulation10.1016/j.colcom.2020.100326 ↗
11. Interfacial phenomena in composites with nanostructured succinic acid bound to hydrophilic and hydrophobic nanosilicas10.1016/j.colcom.2020.100251 ↗
12. Recent advances of designing dynamic surfaces to regulate cell adhesion10.1016/j.colcom.2020.100249 ↗
13. Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: Examples from the DOPPS10.1093/ndt/gfw287 ↗
14. Practice-based versus patient-level outcomes research in hemodialysis: the DOPPS (Dialysis outcomes and practice patterns study) experience10.1053/j.ajkd.2014.05.025 ↗
15. Characterization of protein adsorption on membrane surface by enzyme linked immunoassay10.1016/S0376-7388(00)00484-1 ↗
16. Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility10.1023/B:PHAM.0000036909.41843.18 ↗
17. Dean · 2005
18. Biocompatibility of Polysulfone hemodialysis membranes and its mechanisms: involvement of fibrinogen and its integrin receptors in activation of platelets and neutrophils10.1111/aor.13268 ↗
19. Contact activation: a revision10.1055/s-0038-1657509 ↗
20. Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations10.1039/C5MB00058K ↗
21. Possibilities and limitations of thromboelastometry/thromboelastography
22. Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine10.1056/NEJM199506083322306 ↗
23. The role of complement in biomaterial-induced inflammation10.1016/j.molimm.2006.06.020 ↗
24. Complement: a key system for immune surveillance and homeostasis10.1038/ni.1923 ↗
25. The complement system in hemodialysis patients: getting to the heart of the matter10.1159/000443340 ↗
26. The complement system in Dialysis: a forgotten story?
27. Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis10.1016/j.imbio.2012.07.012 ↗
28. The possible role of factor H in complement activation-related pseudoallergy (CARPA): a failed attempt to correlate blood levels of FH with liposome-induced hypersensitivity reactions in patients with autoimmune disease10.1515/ejnm-2015-0004 ↗
29. Interactions between coagulation and complement - their role in inflammation10.1007/s00281-011-0280-x ↗
30. Human L-ficolin (ficolin-2) and its clinical significance
31. Proteomic analysis of protein adsorption capacity of different haemodialysis membranes10.1039/c2mb05393d ↗
32. Case studies of clinical hemodialysis membranes: influences of membrane morphology and biocompatibility on uremic blood-membrane interactions and inflammatory biomarkers10.1038/s41598-020-71755-8 ↗
33. Biocompatibility enhancement of hemodialysis membranes using a novel zwitterionic copolymer: Experimental, in situ synchrotron imaging, molecular docking, and clinical inflammatory biomarkers investigations
34. A comprehensive computational study and simulation of innovative zwitterionic materials for enhanced poly (vinylidene fluoride) membrane hydrophilicity10.1016/j.jmgm.2020.107656 ↗
35. Latest advances in zwitterionic structures modified dialysis membranes10.1016/j.mtchem.2019.100227 ↗
36. A case study of poly (aryl ether sulfone) hemodialysis membrane interactions with human blood: molecular dynamics simulation and experimental analyses10.1016/j.cmpb.2020.105742 ↗
37. Assessing the contact-activation of coagulation during hemodialysis with three different polysulfone filters: a prospective randomized cross-over trial10.1111/hdi.12509 ↗
38. Biocompatibility of Polysulfone hemodialysis membranes and its mechanisms: involvement of fibrinogen and its integrin receptors in activation of platelets and neutrophils10.1111/aor.13268 ↗
39. Cardiovascular disease in dialysis patients10.1093/ndt/gfy174 ↗
40. Prevalência de fatores de risco cardiovascular em pacientes em hemodiálise - O estudo CORDIAL
41. P-Cresyl sulfate and Indoxyl sulfate in hemodialysis patients10.2215/CJN.02940509 ↗
42. Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study10.1007/s11255-018-2002-y ↗
43. Microparticles, vascular function, and atherothrombosis10.1161/CIRCRESAHA.110.233163 ↗
44. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia10.1177/1076029612436676 ↗
45. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study10.4065/80.8.995 ↗
46. Hemodialysis-induced cardiovascular disease10.1111/sdi.12694 ↗
47. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US renal data system10.1001/jamacardio.2019.0375 ↗
48. Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations
49. Evaluation of the biocompatibility of dialysis membranes10.1159/000441576 ↗
50. Current approaches to middle molecule removal: Room for innovation10.1093/ndt/gfy224 ↗
51. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update10.1053/j.ajkd.2015.07.015 ↗
52. Comparison the effect of high flux and low flux dialyzer on quality of life in hemodialysis patients; a clinical trial10.15171/jrip.2019.19 ↗
53. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial10.1038/ki.2011.213 ↗
54. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study10.1681/ASN.V11122344 ↗
55. Effect of membrane permeability on survival of hemodialysis patients10.1681/ASN.2009010030 ↗
56. Properties of protein adsorption onto pore surface during microfiltration: effects of solution environment and membrane hydrophobicity10.1016/j.memsci.2006.01.039 ↗
57. Electrostatic interactions influence protein adsorption (but not desorption) at the silica-aqueous interface10.1021/acs.jpclett.5b00933 ↗
58. Plasma protein adsorption to highly permeable hemodialysis membranes10.1038/ki.1995.317 ↗
59. Model protein adsorption on polymers explained by Hansen solubility parameters10.1016/j.xphs.2018.06.016 ↗
60. Ascertaining effects of nanoscale polymeric interfaces on competitive protein adsorption at the individual protein level10.1039/C5NR07465G ↗
61. Adsorption and relaxation kinetics of albumin and fibrinogen on hydrophobic surfaces: single-species and competitive behavior10.1021/la990089q ↗
62. How is the surface treatments influence on the roughness of biocompatibility?
63. Protein adsorption on blood-contact membranes10.1016/S0376-7388(03)00313-2 ↗
64. Blood material interactions at the surfaces of membranes in medical applications10.1016/S1383-5866(98)00079-3 ↗
65. The Langmuir isotherm: a commonly applied but misleading approach for the analysis of protein adsorption behavior10.1002/jbm.a.35235 ↗
66. Fibrinogen adsorption to biomaterials10.1002/jbm.a.36460 ↗
67. Modeling of hemodialysis operation10.1007/s10439-010-0147-7 ↗
68. Computational flow modeling in hollow-fiber dialyzers10.1046/j.1525-1594.2002.07081.x ↗
69. The Internal Dynamics of Fibrinogen and Its Implications for Coagulation and Adsorption10.1371/journal.pcbi.1004346 ↗
70. Multiscale modeling and simulations of protein adsorption: progresses and perspectives10.1016/j.cocis.2018.12.004 ↗
71. Methods for studying protein adsorption10.1016/S0076-6879(99)09028-X ↗
72. Chapter 1 proteins: an introduction10.1016/S1569-2582(06)80003-6 ↗
73. Bonomini · 2017 · 1700112 · 10
74. Kinetics of protein adsorption and desorption on surfaces with grafted polymers10.1529/biophysj.104.055079 ↗
75. Time-dependent conformational changes in adsorbed albumin and its effect on platelet adhesion10.1021/la204777x ↗
76. Protein adsorption on polymers10.1016/j.mtcomm.2018.10.024 ↗
77. Proteomics characterization of protein adsorption onto hemodialysis membranes10.1021/pr060150u ↗
78. A Case Study of Poly (aryl ether sulfone) Hemodialysis Membrane Interactions with Human Blood: Molecular Dynamics Simulation and Experimental Analyses10.1016/j.cmpb.2020.105742 ↗
79. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules
80. Canadian Institute for Health Information · 2019
81. Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?10.1111/j.1525-139X.2010.00807.x ↗
82. Mollahosseini · 2020 · 13
83. National Kidney Foundation · 2011
84. Haemodialysis membranes10.1038/s41581-018-0002-x ↗
85. A critical review of recent advances in hemodialysis membranes hemocompatibility and guidelines for future development10.1016/j.matchemphys.2020.122911 ↗
86. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study10.1097/01.ASN.0000096373.13406.94 ↗
87. High-flux or low-flux dialysis: a position statement following publication of the membrane permeability outcome study10.1093/ndt/gfp626 ↗
88. Ambalavanan · 1999
89. Krishnan · 2017
90. The impact of blood flow rate during hemodialysis on all-cause mortality10.3904/kjim.2015.111 ↗
91. 2012
92. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf cooperation council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015)10.4103/1319-2442.194889 ↗
93. The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients
94. Garzotto · 2019
95. The impact of blood flow rate on dialysis dose and phosphate removal in hemodialysis patients10.4103/1319-2442.239654 ↗
96. Effects of plasma proteins on the transport and surface characteristics of Polysulfone/Polyethersulfone and asymmetric cellulose triacetate high flux dialyzers10.1111/aor.13154 ↗
97. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β2-microglobulin during clinical haemodialysis10.1093/ndt/gfq326 ↗
98. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices
99. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use10.1053/ajkd.2001.21296 ↗
100. Dialysate flow rate and delivered kt/v urea for dialyzers with enhanced dialysate flow distribution10.2215/CJN.02630311 ↗